<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Validation of the D:A:D chronic kidney disease risk score in people living with HIV : the IeDEA West Africa Cohort Collaboration</dc:title>
  <dc:creator>Poda, A.</dc:creator>
  <dc:creator>Kabore, N.F.</dc:creator>
  <dc:creator>Malateste, K.</dc:creator>
  <dc:creator>Rekeneire, N. de.</dc:creator>
  <dc:creator>Semde, A.</dc:creator>
  <dc:creator>Bikinga, Y.</dc:creator>
  <dc:creator>Patassi, A.</dc:creator>
  <dc:creator>Chenal, H.</dc:creator>
  <dc:creator>Messou, E.</dc:creator>
  <dc:creator>Dabis, F.</dc:creator>
  <dc:creator>Ekouevi, D.K.</dc:creator>
  <dc:creator>Jaquet, A.</dc:creator>
  <dc:creator>/Cournil, Amandine</dc:creator>
  <dc:description>Objectives: A risk score for long-term prediction of chronic kidney disease (CKD) in people living with HIV (PLHIV) has been developed using data from the D:A:D cohort. We assessed the performance of the D:A:D risk score in a cohort of PLHIV in West Africa. Methods : Data from PLHIV starting antiretroviral treatment in four clinics in Burkina Faso, C&#xF4;te d'Ivoire and Togo participating in the IeDEA West Africa collaboration were analysed. CKD was defined as two consecutive estimated glomerular filtration rates (eGFRs) of &#x2264; 60 mL/min/1.73 m2. The D:A:D score (short version) was calculated using age, gender, nadir CD4 and baseline eGFR and was categorized into low, medium, and high-risk groups. Results : In 14 930 participants (70% female, median age = 38 years; median nadir CD4 count = 183 cells/&#xB5;L) followed for a median duration of 5.7 years, 660 (4.4%) progressed to CKD, with an incidence [95% confidence interval (CI)] of 7.8 (7.2-8.4) per 1000 person-years (PY). CKD incidence rates were 2.4 (2.0-2.8), 8.1 (6.8-9.6) and, 30.9 (28.0-34.1) per 1000 PY in the low-, medium- and high-risk groups, respectively. In the high-risk group, 14.7% (95% CI: 13.3; 16.3) had progressed to CKD at 5 years. Discrimination was good [C-statistics = 0.81 (0.79-0.83)]. In all, 79.4% of people who progressed to CKD were classified in the medium- to high-risk group at baseline (sensitivity) and 66.5% of people classified in the low risk group at baseline did not progress to CKD (specificity). Conclusions : These findings confirm the validity of the D:A:D score in identifying individuals at risk of developing CKD who could benefit from enhanced kidney monitoring in West African HIV clinics</dc:description>
  <dc:date>2021</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010081705</dc:identifier>
  <dc:identifier>fdi:010081705</dc:identifier>
  <dc:identifier>Poda A., Kabore N.F., Malateste K., Rekeneire N. de., Semde A., Bikinga Y., Patassi A., Chenal H., Messou E., Dabis F., Ekouevi D.K., Jaquet A., Cournil Amandine. Validation of the D:A:D chronic kidney disease risk score in people living with HIV : the IeDEA West Africa Cohort Collaboration. 2021, 22 (2), 113-121</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>BENIN</dc:coverage>
  <dc:coverage>BURKINA FASO</dc:coverage>
  <dc:coverage>COTE D'IVOIRE</dc:coverage>
  <dc:coverage>TOGO</dc:coverage>
  <dc:coverage>SENEGAL</dc:coverage>
</oai_dc:dc>
